List of Contract Research Companies in Italy - 6

Anemocyte is an Italian Biotech Manufacturing Organization with a strong focus on the development, manufacturing, and analytical services to address needs in the field of: • pDNA – Plasmids manufacturing (R&D, Hiqh-Quality, and GMP) for Viral Vector and mRNA; • mRNA – mRNA manufacturing (R&D) for vaccines and therapeutic treatments. Our experience: • More than 20 years of development and manufacturing experience (from R&D to GMP) in the field of Cell and Gene Therapies and Nucleic Acids. • Over the years, Anemocyte has been involved in multiple projects with a wide range of complexity.

Driven by our mission to advance research and improve lives, BMR Genomics serves as a trusted partner for both academic and commercial projects in the life sciences. BMR Genomics, a spin-off of the University of Padua, initially focused on providing DNA analysis to universities and research centers. BMR has grown into a leading provider of comprehensive genomics services for researchers, companies, and private individuals across the life sciences sector. In 2008, we were honored with the award for Italy's best start-up. At BMR Genomics, we offer a broad range of advanced services, including DNA sequencing (Sanger, Illumina, and Oxford Nanopore), cell authentication (Cell Profile), DNA genotyping, and bioinformatics support. Additionally, we supply life science lab products through Easy Shop and custom oligonucleotides through Custom Primer. We also cater to private individuals and professionals by providing human identification, paternity, and relative testing. Our expertise spans diverse areas such as medical diagnostics, microbiology, agriculture, veterinary science, and environmental research. With cutting-edge laboratories and a commitment to staying at the forefront of genomics and bioinformatics, we continually innovate to meet the evolving needs of the scientific community. For more information, contact us at commerciale@bmr-genomics.it.

CaSRevolution is a drug discovery company developing innovative therapies for neurodegenerative diseases.

Galileo Research origins lie in 1972 as the Research Centre of Istituto Gentili, an Italian pharmaceutical company founded in 1917. At the beginning of the ‘80s, scientists at the Gentili Research Centre discovered and developed new molecules in the class of bisphosphonates and in the field of bone diseases, in particular clodronate and alendronate. The Research Centre continued to work in the field of bone and joint metabolism and also expanded its knowledge and activities to the areas of oncology and CNS. Galileo Research was established in July 2011.

Lead Discovery Siena - LDS - is an innovative SME focused on the research for new drugs. LDS offers pharmaceutical services for Industry and Academia and has a diversified pipeline of in licensed and proprietary products for oncology and infections therapeutic areas, including rare diseases. LDS was founded as a spin-off of the University of Siena in 2012 by combining the scientific background and the entrepreneurship of its management to offer specific competences and solutions in drug discovery. LDS capitalizes on the wide scientific expertise in pharmacology and medicinal chemistry to efficiently expedite the discovery and development of small molecule medicines. A number of molecules have been successfully advanced by LDS team as evidenced by publications and patents, and several goals achieved in the course of collaborations which earned us the trust of our customers. LDS actively participates to national and international projects, with a special attention to local synergies at industrial and academic level within the Life Science area. LDS laboratories are located in the Toscana Life Sciences facilities (www.toscanalifesciences.org), a non-profit organization supporting research activities and promoting the creation of innovative companies in Life Sciences.

ReiThera is a company devoted to developing and producing biopharmaceutical products based on gene delivery technologies doe advanced therapies, in order to prevent and treat several serious or life-threatening diseases.